The introduction of calibrated vaporisers for volatile anaesthetic agents led to the development of accurate analysers of vaporiser output and monitors of vapour concentration in the anaesthetic breathing system.
The first calibrated vaporiser, the copper kettle, was developed by Lucien Morris in 1951 1 . Because a separate flow of oxygen was fully saturated with ether or chloroform and then added to the remaining gases in a mixing chamber just before entry to the breathing system, the administered vapour concentration was calculated from the gas flows, in each individual case. With the introduction of halothane in 1956, new vaporisers appeared such as the Fluotec Mark 1 where the output concentration of the vaporiser was indicated on a dial, and modifying calculations were only required at very low gas flows. These vaporisers were individually calibrated by the manufacturer using a Rayleigh refractometer, and any subsequent service or repair required a repeat calibration.
The Rayleigh refractometer was originally devised by John William Strutt, the third Baron Rayleigh, in 1896. His childhood education was repeatedly interrupted by poor health, however he commenced studies in mathematics at Cambridge in 1861 at the age of 20. By the time of his death at the age of 76, he had published 446 papers and received the Nobel Prize for physics. His research interests ranged over the whole field of physics, much of which he carried out at his ancestral home, Terling Place. He was particularly interested in colour vision, acoustics and light scattering. In 1879, he was appointed as the Cavendish Professor of Physics and was later the Professor of Natural Philosophy at the Royal Institution. In 1895, with William Ramsey, he isolated argon, for which he received the Nobel Prize in 1904. He developed the refractometer in order to measure argon and helium concentrations 2 .
The refractometer is a delicate laboratory instrument and was unsuitable as a clinical monitor of anaesthetic agent concentration. Gas chromatography was also clearly unsuitable as a clinical monitor. The search for a more portable monitor led to investigation of the absorption of ultraviolet light by halothane. In 1962, Robinson, Denson and Summers of Los Angeles, developed a halothane meter using ultraviolet absorption 3 . Hook and Tucker Ltd in London produced a commercial model, known as the "Hook and Tucker Halothane Meter". The device had a warm-up time of 20 minutes, needed frequent adjustment and was subject to pressure effects 4 .
It was known that rubber absorbed halothane, and this was the principle used in the "Narkotest" halothane meter manufactured by Dräger Medical Ltd, in 1969. The meter contained silicone rubber strips connected by a mechanical lever system to a pointer on a scale. The device was small and could be placed anywhere in the breathing circuit, however because of the effect of water vapour, it was recommended to be used in the inspiratory limb. The Narkotest was also sensitive to carbon dioxide, but at physiological concentrations the effect was minimal. The Narkotest could also be used for other volatile agents, with varying response times. The 95% response time for 1% halothane was around 100 seconds. Frequent zero recalibration was required 5, 6 .
The mass spectrometer can analyse multiple components of a gas mixture. Molecules are first ionised and then accelerated into a vacuum where their path is deflected by an electrostatic and magnetic field according to their mass and charge. Specific collectors count each ion type and are thus able to provide a measure of the concentration of each component in the original sample.
In the late 1960s, some intensive care units installed a single, centrally located respiratory mass spectrometer connected through long sampling catheters to all intensive care unit patients, allowing sequential analysis, with data typically displayed on the central nursing desk. In 1977, Ozanne, Young and Severinghaus installed a similar system to sequentially sample airway gases from each patient in a ten-room operating theatre suite through 30 metre long nylon catheters. In each theatre, terminals showed a time plot of the last 30 minutes of the end-tidal PCO 2 and halothane %, and a table of current values of all sampled end-tidal gases. Users could also monitor data from other operating rooms, send and receive messages to offices and labs, and connect to a local network. Senior anaesthetists could monitor and communicate with residents in any theatre from their office (J. W. Severinghaus, personal communication).
Although these systems were installed in several hundred US hospitals between 1980 and 1992, the capital cost was very high and a trained technician was required to be on-hand. A smaller semi-portable mass spectrometer was developed for use in a single operating theatre. Using a quadrupole magnet where the ionizing chamber is tuned to a particular ion, the monitor was able to accurately monitor only one gas at a time. Still a large and clumsy unit, it proved to be unreliable in clinical use.
The Raman effect occurs when light impinges upon a molecule and interacts with the electron cloud and the bonds of that molecule. Laser radiation is used and, after absorption, the excited molecule re-emits light at a lower energy and different wavelength, each gas having a different specific wavelength. The principle was determined by Sir C. V. Raman in 1928, using sunlight. In 1930, he was the first Indian scientist to win the Nobel Prize 2 .
In 1985, an anaesthetic gas monitor using Raman light-scattering analysis was introduced. Called the RASCAL, it was a large wheeled device, manufactured by Albion Instruments who sold the patent after one year. The RASCAL II, manufactured by Ohmeda, was a combined multigas analyser and pulse oximeter introduced in the early 1990s 7 .
In 1983, the Engstrom company released an anaesthetic gas analyser based on piezoelectric technology. A quartz crystal in an electrical field will vibrate at a natural resonant frequency. By coating the crystal in a lipophilic layer and exposing it to a halogenated anaesthetic, the crystal's resonant frequency changes according to the concentration of the agent in the surrounding gas. Unfortunately, the analyser was non-specific for different agents and sensitive to water vapour 8 .
In 1988, an analyser using photoacoustic spectroscopy was introduced. In 1880, Alexander Graham Bell showed that thin discs emitted sound when exposed to a beam of sunlight that was rapidly interrupted by a rotating slotted disk. He later found that materials exposed to infrared and ultraviolet light can also produce sounds. By using a series of wavelengths, a photoaoustic spectrum can be determined for each gas, and this effect is then used to identify components in a gas mixture. While very accurate, and able to distinguish different agents as well as water vapour, the photoacoustic analyser was expensive and soon superceded by the improving technology in infrared analysers 9 .
The development of the modern infrared gas analysis began with the work of Karl Friedrich Luft in 1937, when he produced a device to measure low concentrations of butane 10 . Initially applied to the measurement of carbon dioxide, refinement in the technology has led to greater accuracy, reliability and ease of use, so that today, infrared analysers are used almost universally for anaesthetic agent monitoring.
In 1987, in the "Clinical Controversy" series in the Journal of Clinical Monitoring, Sir Keith Sykes wrote, "Because there is such a wide variation in the end-tidal anesthetic level required to obtund the stimulus of surgical procedures, there appears to be no point in monitoring end-tidal levels except for research purposes" 11 . Of course, he was presenting one side of a controversial issue of the time, and given the reliability and accuracy of the monitors available, his comment was not inappropriate.
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